Effects of the antimicrobial peptide BMAP-27 in a mouse model of obstructive jaundice stimulated by lipopolysaccharide

Peptides

Volumn 27, Issue 11, 2006, Pages 2592-2599

  Ghiselli, Roberto ^a   Cirioni, Oscar ^a   Giacometti, Andrea ^a   Mocchegiani, Federico ^a   Orlando, Fiorenza ^b   Bergnach, Cristina ^c   Skerlavaj, Barbara ^c   Silvestri, Carmela ^a   Vittoria, Agnese Della ^a   Zanetti, Margherita ^c,d   Rocchi, Marco ^e   Scalise, Giorgio ^a   Saba, Vittorio ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b INRCA   (Italy)

^c UNIVERSITY OF UDINE   (Italy)

^d Natl Lab CIB   (Italy)

^e UNIVERSITY OF URBINO   (Italy)

Author keywords

Bacterial translocation; BMAP 27; Jaundice; Lipopolysaccharide; LPS

Indexed keywords

CATHELICIDIN; ENDOTOXIN; GLYCYLARGINYLPHENYLALANYLLYSYLARGINYLPHENYLALANYLARGINYLLYSYLLYSYLPHENYL ALANYLLYSYLLYSYLLEUCYLPHENYLALANYLLYSYLLYSYLPHENYLALANYLLYSYLLYSYLLEUCYLSERYL PROLYLVALYLISOLEUCYLPROLYLLEUCYLLEUCYLHISTIDYLLEUCINAMIDE; LIPOPOLYSACCHARIDE; PIPERACILLIN PLUS TAZOBACTAM; PLACEBO; POLYPEPTIDE ANTIBIOTIC AGENT; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL TRANSLOCATION; BILE DUCT LIGATION; BLOOD; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFICACY; ESCHERICHIA COLI; LETHALITY; MALE; MOUSE; NONHUMAN; OBSTRUCTIVE JAUNDICE; OUTCOME ASSESSMENT; PERITONEUM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL TRANSLOCATION; DISEASE MODELS, ANIMAL; JAUNDICE, OBSTRUCTIVE; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 33750041675     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2006.05.015     Document Type: Article

References (36)

1. Benincasa M., Skerlavaj B., Gennaro R., Pellegrini A., and Zanetti M. In vitro and in vivo antimicrobial activity of two alpha-helical cathelicidin peptides and of their synthetic analogs. Peptides 24 (2003) 1723-1731
2. Boman H.G. Peptide antibiotics and their role in innate immunity. Ann Rev Immunol 13 (1995) 61-92
3. Bone R.C. Pathophysiology of sepsis. Ann Intern Med 115 (1991) 457-469
4. Buck M.A., Olah T.A., Weitzmann C.J., and Cooperman B.S. Protein estimation by the product of integrated peak area and flow rate. Anal Biochem 182 (1989) 295-299
5. Caǧlikǖlekci M., Pata C., Apa D.D., Dirlik M., Tamer L., Yaylak F., et al. The effect of N-acetylcysteine (NAC) on liver and renal tissue inducible nitric oxide synthase (iNOS) and tissue lipid peroxidation in obstructive jaundice stimulated by lipopolysaccharide (LPS). Pharmacol Res 49 (2004) 227-238
6. Cannon M. A family of wound healers. Nature 328 (1987) 478
7. Chen Q., Wade D., Kurosaka K., Wang Z.Y., Oppenheim J.J., Yang D., et al. A and related frog antimicrobial peptides use formyl peptide receptor-like1 as a receptor to chemoattract phagocytes. J Immunol 173 (2004) 2652-2659
8. Clements W.D., Erwin P., McCaigue M.D., Halliday I., Barclay G.R., and Rowlands B.J. Conclusive evidence of endotoxaemia in biliary obstruction. Gut 42 (1998) 293-299
9. Di Nardo A., Vitiello A., and Gallo R.L. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J Immunol 12 (2003) 2274-2278
10. Ding L., Yang L., Weiss T.M., Waring A.J., Lehrer R.I., and Huang H.W. Interaction of antimicrobial peptides with lipopolysaccharides. Biochemistry 42 (2003) 12251-12259
11. Gennaro R., and Zanetti M. Structural features and biological activities of the cathelicidin-derived antimicrobial peptides. Biopolymers 55 (2000) 31-49
12. Ghiselli R., Giacometti A., Cirioni O., Circo R., Mocchegiani F., Skerlavaj B., et al. Neutralization of endotoxin in vitro and in vivo by Bac7(1-35), a proline-rich antibacterial peptide. Shock 19 (2003) 577-581
13. Giacometti A., Cirioni O., Ghiselli R., Mocchegiani F., D'Amato G., Circo R., et al. Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock. Am J Resp Crit Care Med 169 (2004) 187-194
14. Hancock R.E.W., and Chapple D.S. Peptide antibiotics. Antimicrob Agents Chemother 43 (1999) 1317-1323
15. Hancock R.E.W., and Scott M.G. The role of antimicrobial peptides in animal defenses. Proc Natl Acad Sci USA 97 (2000) 856-861
16. Hardaway R.M. A review of septic shock. Am Surg 66 (1999) 22-29
17. Hoffman W.D., Danner R.L., Quezado Z.M., Banks S.M., Elin R.J., Hosseini J.M., et al. Role of endotoxemia in cardiovascular dysfunction and lethality: virulent and nonvirulent Escherichia coli challenges in a canine model of septic shock. Infect Immunol 64 (1996) 406-412
18. Iwagaki A., Porro M., and Pollack M. Influence of synthetic antiendotoxin eptides on lipopolysaccharide (LPS) recognition and LPS-induced proinflammatory cytokine responses by cells expressing membrane-bound CD14. Infect Immunol 68 (2000) 1655-1663
19. Jourdain M., Carrette O., Tournoys A., Fourrier F., Mizon C., Mangalaboyi J., et al. Effects of inter-α-inhibitor in experimental endotoxic shock and disseminated intravascular coagulation. Am J Resp Crit Care Med 156 (1997) 1825-1833
20. Kennedy J.A., Lewis H., Clements W.D., Kirk S.J., Campbell G., Halliday M.I., et al. Kupffer cell blockade, tumour necrosis factor secretion and survival following endotoxin chellenge in experimental biliary obstruction. Br J Surg 86 (1999) 1410-1414
21. Kordzaya D.J., and Goderdzishvili V.T. Bacterial translocation in obstructive jaundice in rats: role of mucosal lacteals. Eur J Surg 166 (2000) 367-374
22. Koutelidakis I., Papaziogas B., Giamarellos-Bourboulis E.J., Makris J., Pavlidis T., Giamarellou H., et al. Systemic endotoxaemia following obstructive jaundice: the role of lactulose. J Surg Res 113 (2003) 243-247
23. Lamping N., Dettmer R., Schröder N.W.J., Pfeil D., Hallatschek W., Burger R., et al. LPS-binding protein protects mice from septic shock caused by LPS or Gram-negative bacteria. J Clin Invest 101 (1998) 2065-2071
24. Lee S.H., Chae K.S., Nan J.X., and Sohn D.H. The increment of purine specific sodium nucleoside cotransporter mRNA in experimental fibrotic liver induced by bile duct ligation and scission. Arch Pharm Res 23 (2000) 613-619
25. Levy O. Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents. Blood 96 (2000) 2664-2672
26. Mesotten D., Van den Berghe G., Liddle C., Coulter S., McDougall F., Baxter R.C., et al. Growth hormone modulation of the rat hepatic bile transporter system in endotoxin-induced cholestasis. Endocrinology 144 (2003) 4008-4017
27. Nieuwenhuijs V.B., van Dijk J.E., Gooszen H.G., and Akkermans L.M. Ostructive jaundice, bacterial translocation and interdigestive small-bowel motility in rats. Digestion 62 (2000) 255-261
28. Parks R.W., Stuart Cameron C.H., Gannon C.D., Pope C., Diamond T., and Rowlands B.J. Changes in gastrointestinal morphology associated with obstructive jaundice. J Pathol 192 (2000) 526-532
29. Schimpl G., Pabst M.A., Feierl G., Kuesz A., Ozbey H., Takahashi S., et al. A tungsten supplemented diet attenuates bacterial translocation in chronic portal hypertensive and cholestatic rats: role of xanthine dehydrogenase and xanthine oxidase. Gut 45 (1999) 904-910
30. Schimpl G., Pesendorfer P., Steinwender G., Feierl G., Ratschek M., and Hollwarth M.E. Allopurinol and glutamine attenuate bacterial translocation in chronic portal hypertensive and common duct ligated growing rats. Gut 39 (1996) 48-53
31. Scott M.G., Davidson D.J., Gold M.R., Bowdish D., and Hancock R.E. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune rsponses. J Immunol 169 (2002) 3883-3891
32. Sewnath M.E., Levels H.H.M., Elferink R.O., van Noorden C.J., ten Kate F.J., van Deventer S.J., et al. Endotoxin-induced mortality in bile duct-ligated rats after administration of reconstituted high-density lipoprotein. Hepatology 32 (2000) 1289-1299
33. Skerlavaj B., Gennaro R., Bagella L., Merluzzi L., Risso A., and Zanetti M. Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities. J Biol Chem 271 (1996) 28375-28381
34. Swain M.G. Cytokines and neuroendocrine dysregulation in obstructive cholestasis: pathophysiological implications. J Hepatol 35 (2001) 416-418
35. Tomioka M., Iinuma H., and Okinaga K. Impaired Kupffer cell function and effect of immunotherapy in obstructive jaundice. J Surg Res 92 (2000) 276-282
36. Zanetti M., Gennaro R., and Romeo D. Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett 374 (1995) 1-5